We are pleased to announce that the collaborative rapid assessment, OTCA16, on “BIORESORBABLE STENTS FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS (CORONARY ARTERY DISEASE)” is now available.
The health technology assessed is a device for percutaneous coronary intervention (PCI). The objective of this assessment was to evaluate the relative effectiveness and safety of this technology in contrast to the traditional revascularisation strategies PCI using permanent metallic stents and coronary artery bypass graft surgery (CABG).
Below is the documentation provided by the assessment authoring team:
OTCA16 Final Assessment Report HERE
OTCA16 Combined Comments and Author Answers from External Experts and Manufacturer HERE
OTCA16 Project Plan HERE
OTCA16 Project Plan External Expert & Manufacturer Comments HERE
